PI Publications
- 2025Design, Production, and Optimization of Antigen-Specific Recombinant Antitumor Dimeric IgA Antibody. Methods in Molecular Biology. 2025;2909:119-129. PMID: 40029519.
Tamuli B, Ghagare R, Mandal G
AXL/GAS6 signaling governs differentiation of tumor-associated macrophages in breast cancer. Experimental Cell Research. 2025 Jan 1;444(1):114324. Epub 2024 Nov 6. PMID: 39510154.Purohit S, Mandal G, Biswas S, Dalui S, Gupta A, Chowdhury SR, Bhattacharyya A
- 2024
- 2023Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers. Immunity. 2023 Nov 14;56(11):2570-2583.e6. doi: 10.1016/j.immuni.2023.09.013. Epub 2023 Oct 30. PMID: 37909039. *CO-FIRST AUTHOR.
Biswas S, Mandal G, Anadon CM, Chaurio RA, Lopez-Bailon LU, Nagy MZ, Mine JA, Hänggi K, Sprenger KB, Innamarato P, Harro CM, Powers JJ, Johnson J, Fang B, Eysha M, Nan X, Li R, Perez BA, Curiel TJ, Yu X, Rodriguez PC, Conejo-Garcia JR
Sézary syndrome originates from heavily mutated hematopoietic progenitors. Blood Advances. 2023 Sep 26;7(18):5586-5602. PMID: 37531660.Harro CM, Sprenger KB, Chaurio RA, Powers JJ, Innamarato P, Anadon CM, Zhang Y, Biswas S, Mandal G, Mine JA, Cortina C, Nagy MZ, Martin AL, Handley KF, Borjas GJ, Chen PL, Pinilla-Ibarz J, Sokol L, Yu X, Conejo-Garcia JR
Virtual alignment of pathology image series for multi-gigapixel whole slide images. Nature Communications. 2023 Jul 26;14(1):4502. doi: 10.1038/s41467-023-40218-9. PMID: 37495577.Gatenbee CD, Baker AM, Prabhakaran S, Swinyard O, Slebos RJC, Mandal G, Mulholland E, Andor N, Marusyk A, Leedham S, Conejo-Garcia JR, Chung CH, Robertson-Tessi M, Graham TA, Anderson ARA
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma. Gynecologic Oncology. 2023 Apr 28;173:114-121. PMID: 37121178.Handley KF, Mehta S, Martin AL, Biswas S, Maharaj K, Nagy MZ, Mine JA, Cortina C, Yu X, Sprenger K, Mandal G, Innamarato P, Powers JJ, Harro CM, Chaurio RA, Anadon CM, Shahzad MM, Flores I, Conejo-Garcia JR
- 2022Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors. Molecular Cancer Therapeutics. 2022 Jul 5;21(7):1184-1194.PMID: 35499393.
Martin AL, Anadon CM, Biswas S, Mine JA, Handley KF, Payne KK, Mandal G, Chaurio RA, Powers JJ, Sprenger KB, Rigolizzo KE, Innamarato P, Harro CM, Mehta S, Perez BA, Wenham RM, Conejo-Garcia JR
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell. 2022 May 9;40(5):545-557.e13 PMID: 35427494.Anadon CM, Yu X, Hänggi K, Biswas S, Chaurio RA, Martin A, Payne KK, Mandal G, Innamarato P, Harro CM, Mine JA, Sprenger KB, Cortina C, Powers JJ, Costich TL, Perez BA, Gatenbee CD, Prabhakaran S, Marchion D, Heemskerk MHM, Curiel TJ, Anderson AR, Wenham RM, Rodriguez PC, Conejo-Garcia JR
TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures. Immunity. 2022 Jan 11;55(1):115-128.e9.PMID: 35021053.Chaurio RA, Anadon CM, Lee Costich T, Payne KK, Biswas S, Harro CM, Moran C, Ortiz AC, Cortina C, Rigolizzo KE, Sprenger KB, Mine JA, Innamarato P, Mandal G, Powers JJ, Martin A, Wang Z, Mehta S, Perez BA, Li R, Robinson J, Kroeger JL, Curiel TJ, Yu X, Rodriguez PC, Conejo-Garcia JR
IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer. Cancer Research. 2022 Mar 1;82(5):859-871.PMID: 34949671.Mandal G, Biswas S, Anadon CM, Yu X, Gatenbee CD, Prabhakaran S, Payne KK, Chaurio RA, Martin A, Innamarato P, Moran C, Powers JJ, Harro CM, Mine JA, Sprenger KB, Rigolizzo KE, Wang X, Curiel TJ, Rodriguez PC, Anderson AR, Saglam O, Conejo-Garcia JR
- 2021IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021 Mar;591(7850):464-470. Epub 2021 Feb 3. PMID: 33536615.
Biswas S, Mandal G, Payne KK, Anadon C, Gatenbee CD, Chaurio RA, Costich TL, Harro CM, Rigolizzo KE, Mine A, Moran, C, Trillo-Tinoco J, Sasamoto N, Terry KL, Marchion D, Buras A, Wenham RM, Yu X, Townsend MK, Tworoger SS, Rodriguez PC, Anderson AR, Conejo-Garcia JR
Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. Journal of Clinical Investigation. 2020 Dec 3; doi: 10.1172/JCI135711. PMID: 33270606.Harro CM, Perez-Sanz J, Costich TL, Payne KK, Anadon Galindo CM, Chaurio RA, Biswas S, Mandal G, Rigolizzo KE, Sprenger KB, Mine JA, Showe L, Yu X, Liu K, Rodriguez PC, Pinilla-Ibarz J, Sokol L, Conejo-Garcia JR
- 2020BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science. 2020 Aug 21;369(6506):942-949. doi: 10.1126/science.aay2767. PMID: 32820120.
Payne KK, Mine JA, Biswas S, Chaurio RA, Perales-Puchalt A, Anadon CM, Costich TL, Harro CM, Walrath J, Ming Q, Tcyganov E, Buras AL, Rigolizzo KE, Mandal G, Lajoie J, Ophir M, Tchou J, Marchion D, Luca VC, Bobrowicz P, McLaughlin B, Eskiocak U, Schmidt M, Cubillos-Ruiz JR, Rodriguez PC, Gabrilovich DI, Conejo-Garcia JR
- 2019Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer. The Journal of Immunology. 2019 Dec 15;203(12):3447-3460. doi: 10.4049/jimmunol.1900692. Epub 2019 Nov 8. PMID: 31704881
Biswas S, Mandal G*, Roy Chowdhury S, Purohit S, Payne KK, Anadon C, Gupta A, Swanson P, Yu X, Conejo-Garcia JR, Bhattacharyya A
MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer. British Journal of Cancer. 2019 Oct;121(8):679-689. Epub 2019 Sep 4. PMID: 31481734.Chatterjee A, Jana S, Chatterjee S, Wastall LM, Mandal G, Nargis N, Roy H, Hughes TA, Bhattacharyya A
RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression. Biochimica et Biophysica Acta-Molecular Basis of Disease. 2019 Feb 1;1865(2):502-511. doi: 10.1016/j.bbadis.2018.12.002. Epub 2018 Dec 12. PMID: 30553016.Biswas S, Roy Chowdhury S, Mandal G, Purohit S, Gupta A, Bhattacharyya A
- 2018Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression. Biochimica et Biophysica Acta-Molecular Basis of Disease. 2018 Jun;1864(6 Pt A):2053-2066. Epub 2018 Mar 8. PMID: 29526821.
Mandal G, Biswas S, Roy Chowdhury S, Chatterjee A, Purohit S, Khamaru P, Chakraborty S, Mandal PK, Gupta A, de la Mare JA, Edkins AL, Bhattacharyya A
CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression. Immunobiology. 2018 Feb;223(2):151-161. Epub 2017 Oct 16. PMID: 29107385.Mandal PK, Biswas S, Mandal G, Purohit S, Gupta A, Majumdar Giri A, Roy Chowdhury S, Bhattacharyya A
- 2017
- 2013CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis. Breast Cancer Research and Treatment. 2014 Jan;143(2):265-76. Epub 2013 Dec 13. PMID: 24337540.
Biswas S, Sengupta S, Roy Chowdhury S, Jana S, Mandal G, Mandal PK, Saha N, Malhotra V, Gupta A, Kuprash DV, Bhattacharyya A